文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

限制机械通气患者的动态驱动压

Limiting Dynamic Driving Pressure in Patients Requiring Mechanical Ventilation.
PubMed 文献 · Crit Care Med · 2023-03-27
一句话结论在传统肺保护性通气基础上,将每日动态驱动压限制在≤15 cm H2O可使调整后死亡率从20.1%降至18.1%(RR 0.90,95%CI 0.89-0.92)。

该比较效果研究利用加拿大多伦多重症监护观察登记库(2014年4月至2021年8月,7家附属医院9个ICU)数据,模拟 pragmatic 临床试验,纳入12,865例需要机械通气≥24小时的成人患者,评估在传统肺保护性通气基础上将每日静态或动态驱动压限制在≤15 cm H2O的效果。结果:常规治疗下死亡率为20.1%(95%CI 19.4-20.9%);限制动态驱动压≤15 cm H2O使依从性调整后死亡率降至18.1%(95%CI 17.5-18.9%),风险比0.90(95%CI 0.89-0.92)。该效应在早期且持续干预时最为明显;基线静态驱动压仅在2,473例中有记录,但观察到类似效应。相反,无论驱动压如何,严格限制潮气量或峰值吸气压力并未降低死亡率。结论:限制静态或动态驱动压可进一步降低需要机械通气患者的死亡率。

要点

  • 在传统肺保护性通气基础上,将每日动态驱动压限制在≤15 cm H2O可使调整后死亡率从20.1%降至18.1%(RR 0.90,95%CI 0.89-0.92)。
  • 基线时35%(4,468/12,865)的患者动态驱动压>15 cm H2O。
  • 该效应在早期且持续干预时最为明显。
  • 基线静态驱动压仅在2,473例中有记录,但观察到类似效应。
  • 无论驱动压如何,严格限制潮气量或峰值吸气压力并未降低死亡率。

适用人群与场景

  • 成人患者(≥18岁),需要有创机械通气≥24小时,数据来自7家多伦多大学附属医院的9个ICU(2014年4月至2021年8月)。

诊断标准与关键阈值

  • 干预策略:将每日静态或动态驱动压限制在≤15 cm H2O,与常规治疗比较。

处置流程与药物剂量

  • 在传统肺保护性通气基础上,限制每日动态驱动压≤15 cm H2O;限制每日静态驱动压≤15 cm H2O也观察到类似效应。

研究设计与关键结果

  • 比较效果研究,采用参数g-formula模拟 pragmatic 临床试验,控制基线和时间变化混杂及竞争事件;纳入12,865例成人机械通气≥24小时患者,来自9个ICU。
  • 常规治疗下死亡率为20.1%(95%CI 19.4-20.9%)。
  • 限制每日动态驱动压≤15 cm H2O使依从性调整后死亡率降至18.1%(95%CI 17.5-18.9%),风险比0.90(95%CI 0.89-0.92)。
  • 该效应在早期且持续干预时最为明显。
  • 基线静态驱动压仅在2,473例中有记录,但观察到类似效应。
  • 相反,无论驱动压如何,严格限制潮气量或峰值吸气压力并未降低死亡率。

证据类型、等级与局限

  • 比较效果研究(模拟 pragmatic 临床试验),利用观察性登记数据,采用参数g-formula方法控制混杂和竞争事件。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 对于需要机械通气≥24小时的成人患者,在传统肺保护性通气基础上限制动态或静态驱动压≤15 cm H2O可能进一步降低死亡率,尤其应早期且持续实施;严格限制潮气量或峰值吸气压力而未关注驱动压并未降低死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Previous studies reported an association between higher driving pressure (∆P) and increased mortality for different groups of mechanically ventilated patients. However, it remained unclear if sustained intervention on ∆P, in addition to traditional lung-protective ventilation, improves outcomes. We investigated if ventilation strategies limiting daily static or dynamic ∆P reduce mortality compared with usual care in adult patients requiring greater than or equal to 24 hours of mechanical ventilation.

DESIGN: For this comparative effectiveness study, we emulated pragmatic clinical trials using data from the Toronto Intensive Care Observational Registry recorded between April 2014 and August 2021. The per-protocol effect of the interventions was estimated using the parametric g-formula, a method that controls for baseline and time-varying confounding, as well as for competing events in the analysis of longitudinal exposures.

SETTING: Nine ICUs from seven University of Toronto-affiliated hospitals.

PATIENTS: Adult patients (≥18 yr) requiring greater than or equal to 24 hours of mechanical ventilation.

INTERVENTIONS: Receipt of a ventilation strategy that limited either daily static or dynamic ∆P less than or equal to 15 cm H 2 O compared with usual care.

MEASUREMENTS AND MAIN RESULTS: Among the 12,865 eligible patients, 4,468 of (35%) were ventilated with dynamic ∆P greater than 15 cm H 2 O at baseline. Mortality under usual care was 20.1% (95% CI, 19.4-20.9%). Limiting daily dynamic ∆P less than or equal to 15 cm H 2 O in addition to traditional lung-protective ventilation reduced adherence-adjusted mortality to 18.1% (95% CI, 17.5-18.9%) (risk ratio, 0.90; 95% CI, 0.89-0.92). In further analyses, this effect was most pronounced for early and sustained interventions. Static ∆P at baseline were recorded in only 2,473 patients but similar effects were observed. Conversely, strict interventions on tidal volumes or peak inspiratory pressures, irrespective of ∆P, did not reduce mortality compared with usual care.

CONCLUSIONS: Limiting either static or dynamic ∆P can further reduce the mortality of patients requiring mechanical ventilation.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Urner M, Jüni P, Rojas-Saunero LP, et al. Limiting Dynamic Driving Pressure in Patients Requiring Mechanical Ventilation. Crit Care Med. 2023. PMID: 36971437. doi:10.1097/CCM.0000000000005844

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。